Vasoactive Renal Factors and the Progression of Diabetic Nephropathy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|27|3373-3384

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.27, 2004-10, pp. : 3373-3384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Suppressing renal NADPH oxidase to treat diabetic nephropathy

By Tojo Akihiro   Asaba Kensuke   Onozato Maristela L  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 8, 2007-08 ,pp. : 1011-1018

Informa Healthcare

Access to resources Recommend Favorite

Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy

By  

Current Medicinal Chemistry, Vol. 24, Iss. 31, 2017-10 ,pp. : 3397-3412

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic nephropathy

By Wylie Emma C   Satchell Simon C  

Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. : 480-482

Royal College Of Physicians

Access to resources Recommend Favorite

Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-01 ,pp. : 3331-3348

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic Targets

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 42-50

Bentham Science Publishers

Access to resources Recommend Favorite